TrialDiabetes, obesity & metabolism2026

Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double-blind, placebo-controlled trial.

Hisashi Makino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.